Static lung compliance and DLCO often demonstrate parenchymal involvement in sarcoidosis despite a normal total lung capacity Source: Annual Congress 2009 - Sarcoidosis in review Year: 2009
Lung volumes, diffusing capacity and static lung compliance in patients with UIP pattern of IPF Source: Eur Respir J 2002; 20: Suppl. 38, 62s Year: 2002
Exercise limitation in patients with interstitial lung disease independent from diffusion capacity (DLCO) Source: Annual Congress 2008 - Exercise: system responses Year: 2008
Total lung capacity (TLC) or vital capacity (VC) - which is more reduced in interstitial lung disease (ILD) patients? Source: Eur Respir J 2001; 18: Suppl. 33, 150s Year: 2001
Impaired lung compliance and DL,CO but no restrictive ventilatory defect in sarcoidosis Source: Eur Respir J 2010; 36: 1315-1322 Year: 2010
Paradoxically normal lung volume assessed by CXR and total lung capacity in patients with diffuse pulmondary fibrosis and additional emphysema Source: Eur Respir J 2006; 28: Suppl. 50, 98s Year: 2006
Lung compliance in patients with pulmonary fibrosis with normal lung volumes Source: Eur Respir J 2007; 30: Suppl. 51, 577s Year: 2007
Differences in the pattern of FEV1 and VC change after lung resection between lung cancer patients with limited and normal lung function Source: Eur Respir J 2006; 28: Suppl. 50, 278s Year: 2006
A comparison between total lung capacity and effective alveolar volume in patients with restrictive lung disease Source: Eur Respir J 2005; 26: Suppl. 49, 180s Year: 2005
Influence of smoking habit on static lung compliance (Cst) in interstitial lung diseases (ILD) patients Source: Eur Respir J 2002; 20: Suppl. 38, 194s Year: 2002
Lung diffusion measurement: effects of alveolar volume changes on diffusing capacity and implications in restrictive lung disease Source: Annual Congress 2004 - PG13 - Lung diffusion measurements in diseases Year: 2004
Ability for dynamic hyperinflation increases after bronchoscopic lung volume reduction in patients with severe emphysema. Source: International Congress 2017 – Endoscopic lung volume reduction (EVLR) and targeted lung denervation (TLD) Year: 2017
Flow-volume parameters in COPD related to extended measurements of lung volume, diffusion and resistance Source: Annual Congress 2013 –Lung function tests to monitor airway diseases Year: 2013
Static and dynamic compliance in patients with scleroderma and normal lung function Source: Eur Respir J 2006; 28: Suppl. 50, 100s Year: 2006
Static and dynamic lung compliance in patients with pulmonary fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 98s Year: 2006
Correlation between spirometric indices (FEV1, FVC) and lung diffusion values (DLCO) in subjects with varying severity of chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2007 - Primary care respiratory problems Year: 2007
Roles of transthoracic lung ultrasonography in diagnosis of interstitial lung disease: correlation with HRCT, vital capacity, diffusing of the lung for monoxide test Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia Year: 2018
Effect of posture on lung clearance index (LCI) and lung volumes in children with early stage cystic fibrosis lung disease Source: International Congress 2015 – Lung function: effects on method, machine and disease on the measurement Year: 2015
Forced vital capacity, total lung capacity and diffusion capacity in idiopathic pulmonary fibrosis Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018
Relationships between angiogenic activity of sera from interstitial lung disease (ILD) patients and lung function tests Source: Eur Respir J 2002; 20: Suppl. 38, 106s Year: 2002